Charcot-Marie-Tooth Disease Type 1D (CMT1D)

Charcot-Marie-Tooth disease type 1D (CMT1D) is a rare, inherited nerve disease. It mainly affects the “peripheral nerves”. These are the long nerves that carry signals between your brain, spinal cord, muscles, and skin. In CMT1D, these nerves do not work properly because their insulation layer, called “myelin”, is damaged. This makes nerve signals slow and weak. CMT1D is a sub-type of Charcot-Marie-Tooth type 1 (CMT1), which is a group of demyelinating neuropathies (nerve diseases with myelin damage). MalaCards+1

Charcot-Marie-Tooth disease type 1D (CMT1D) is a rare, inherited nerve disease. It mainly affects the long nerves in the legs, feet, hands, and arms. In CMT1D, there is a change (mutation) in a gene called EGR2. This gene helps control how myelin, the “insulation” around nerves, is made. When EGR2 does not work properly, the myelin becomes weak or abnormal, and nerve signals travel more slowly. This leads to muscle weakness, thin muscles, foot deformities, and problems with walking and balance. Genetic & Rare Diseases Center+2National Organization for Rare Disorders+2

CMT1D usually starts with gait (walking) problems and weakness of the muscles in the feet and lower legs. Over time, weakness can move upward and may also affect the hands. People may develop high-arched feet, hammertoes, and reduced reflexes. Some can also have scoliosis (curved spine), eye movement problems, or vocal cord weakness, but this is less common. The disease usually progresses slowly over many years, and life expectancy is often near normal, but disability can be significant. Genetic & Rare Diseases Center+2Mayo Clinic+2

The main medical cause of CMT1D is a change (mutation) in a gene called EGR2 (early growth response 2) on chromosome 10. This gene gives instructions for making a protein that helps Schwann cells form and keep healthy myelin around peripheral nerves. When EGR2 is changed, Schwann cells cannot make normal myelin, so nerves become demyelinated, and then muscles and feeling in the hands and feet are slowly affected. Orpha+2Wikipedia+2

CMT1D is usually passed on in an autosomal dominant way. This means that a person can get the disease if they inherit just one changed copy of the EGR2 gene from either parent. In some people, the mutation appears for the first time (a “de novo” change), with no clear family history. CMT1D can start at many ages, from infancy to adult life. The disease often progresses slowly over many years and usually does not affect life span, but it can cause disability, walking problems, and hand weakness. Global Genes+2NCBI+2

Another names of Charcot-Marie-Tooth disease type 1D

Doctors and researchers use several other names for CMT1D. All of these refer to the same basic condition:

1. Charcot-Marie-Tooth disease type 1D (CMT1D) – the most common short name. Orpha+1

2. Charcot-Marie-Tooth neuropathy type 1D – stresses that it is a neuropathy (nerve disease). ZFIN+1

3. Charcot-Marie-Tooth disease, demyelinating, type 1D – explains that the main problem is demyelination. NCBI+1

4. Hereditary motor and sensory neuropathy 1D (HMSN 1D or HMSN1D) – an older name which means both movement (motor) and feeling (sensory) nerves are involved. NCBI+2GlyCosmos+2

5. EGR2-related Charcot-Marie-Tooth disease – used when the genetic cause (EGR2 mutation) is known. Nature+1

Types of Charcot-Marie-Tooth disease type 1D

CMT1D is one genetic type of CMT1, but inside this type there can still be different clinical forms. Doctors usually describe these forms based on how early the disease starts, how severe it is, and what signs appear, rather than using completely new official subtype codes. Global Genes+1

1. Classic childhood-onset CMT1D
   In this form, symptoms start in late childhood or early teenage years. Children may develop high arches in the feet, ankle weakness, and difficulty running or keeping up with friends. Nerve conduction tests show slow conduction, typical of demyelinating neuropathy. MalaCards+1

2. Early-onset severe CMT1D
   Some babies or toddlers with EGR2 mutations develop symptoms very early. They may be late to sit, stand, or walk, and may have weak muscles and reduced reflexes from infancy. In some cases, the picture can overlap with very severe forms like Dejerine–Sottas neuropathy or congenital hypomyelinating neuropathy, which are also linked to EGR2. Nature+2Wiley Online Library+2

3. Mild adult-onset CMT1D
   In other people, symptoms appear only in adult life and are mild. They may notice ankle instability, easy tripping, or slight numbness, but can still walk independently. Nerve tests still show clear demyelination, but muscle wasting and deformities are less marked. Global Genes+1

4. CMT1D with cranial nerve involvement
   Some EGR2 mutations can cause extra signs such as double vision, facial weakness, or vocal cord paralysis. These problems come from involvement of cranial nerves, not only the limb nerves. This form shows that EGR2-related neuropathies can affect both peripheral and some central pathways. Global Genes+2Mattioli 1885+2

5. CMT1D with scoliosis or spine problems
   In several reports, people with CMT1D also have scoliosis (sideways curve of the spine). This may be due to long-term muscle imbalance around the spine. It is not a separate genetic type but a clinical pattern that doctors watch for because it may need orthopedic care. Global Genes+1

Causes

The main true cause of CMT1D is a pathogenic mutation in the EGR2 gene. All other “causes” below describe aspects of this genetic problem, how it happens, and how it affects the body.

1. EGR2 gene mutation (core cause)
   CMT1D happens when there is a harmful change in the EGR2 gene. EGR2 is a transcription factor that turns on many genes needed for normal myelin in peripheral nerves. When this gene is faulty, myelin does not form or stay healthy, causing chronic demyelinating neuropathy. Wikipedia+2MalaCards+2

2. Autosomal dominant inheritance
   In most families, CMT1D is inherited in an autosomal dominant pattern. A person with one mutated EGR2 gene has a high chance to pass it on to each child. This explains why the disease often appears in several generations of one family. NCBI+1

3. De novo (new) mutation
   Sometimes, a child with CMT1D is the first in the family to have the disease. In these cases, the EGR2 mutation arises “de novo” in the egg, sperm, or very early embryo. The child can still pass the mutation to their own children later. Nature+1

4. Missense mutations in functional domains of EGR2
   Many CMT1D cases are caused by missense changes (one amino acid swapped for another) in important parts of the EGR2 protein, such as the zinc-finger DNA-binding domains. These changes can alter how strongly EGR2 binds DNA and regulates myelin genes. ScienceDirect+1

5. Loss-of-function or gain-of-function effects
   Different EGR2 mutations may either reduce its activity (loss-of-function) or cause abnormal, toxic activity (gain-of-function). Both types can disturb the carefully balanced network of myelin gene expression and lead to demyelinating neuropathy. ScienceDirect+1

6. Schwann cell dysfunction
   Schwann cells make myelin in peripheral nerves. When EGR2 is abnormal, Schwann cells cannot mature properly. They may fail to wrap axons with normal myelin or may form unstable myelin that breaks down early, producing chronic demyelination. Wikipedia+1

7. Segmental demyelination and remyelination
   Because Schwann cells are unstable, myelin is repeatedly lost and partly rebuilt. This “on–off” pattern causes segmental demyelination and remyelination, which in nerve biopsies can form “onion bulb” changes. Over time, this pattern contributes to very slow nerve conduction and clinical weakness. MalaCards+1

8. Secondary axonal loss
   Long-lasting demyelination stresses the underlying axon (the core of the nerve fiber). Eventually some axons degenerate. This secondary axonal damage adds to muscle wasting and loss of sensation, especially in the feet and hands. Wikipedia+1

9. Length-dependent nerve vulnerability
   The longest nerves are affected first because signals must travel the greatest distance. That is why symptoms start in the feet and later move up the legs and to the hands. This “length-dependent” pattern is typical for CMT, including CMT1D. NCBI+1

10. Genetic heterogeneity within EGR2
    Different families with CMT1D may have different specific mutations in EGR2. Some cause very early and severe disease; others cause milder, later-onset forms. This genetic variety explains why severity and age of onset are so variable even though the same gene is involved. Nature+2Wiley Online Library+2

11. Modifier genes and background CMT genes
    CMT is a genetically complex group of diseases. Other genes that regulate myelin, axonal health, or mitochondria may “modify” the effect of an EGR2 mutation. These modifiers do not cause CMT1D by themselves but can make symptoms better or worse. Taylor & Francis Online+1

12. Family history of CMT or other hereditary neuropathies
    A strong family history shows that a disease-causing mutation is segregating in the family. In CMT1D families, EGR2 changes often co-exist with other hereditary neuropathies, making the pattern of weakness and deformity more complex. nhs.uk+1

13. Epigenetic and regulatory influences
    EGR2 is a transcription factor controlled by other regulatory proteins. Changes in these upstream regulators or in epigenetic marks (for example DNA methylation) may alter how strongly the mutant gene is expressed, and thus influence disease severity. This does not create CMT1D alone but modifies its expression. Wikipedia+1

14. Co-existing acquired neuropathy (for example diabetes)
    Some people with genetic CMT also develop an acquired neuropathy such as diabetic neuropathy or vitamin deficiency. These extra problems do not change EGR2, but they add further nerve damage, so symptoms appear more severe. Mayo Clinic+1

15. Mechanical stress on already weak nerves
    Repeated ankle sprains, foot injuries, or poorly fitting shoes do not cause CMT1D, but they can worsen foot deformities and nerve irritation in people who already have fragile nerves due to EGR2 mutation. Mayo Clinic+1

16. Malalignment of joints and abnormal biomechanics
    High arches, hammertoes, and muscle imbalance change how forces pass through the foot and leg. Over time, these mechanical problems can accelerate nerve and muscle strain, making walking harder, although they are secondary to the original genetic cause. Mayo Clinic+1

17. Poor muscle conditioning
    Because nerves are weak, people often reduce activity. Less use leads to further muscle wasting and stiffness. This “disuse atrophy” is not the primary cause but deepens disability. NCBI+1

18. Age-related nerve changes
    As people grow older, normal nerves slowly lose function. In someone with CMT1D, these normal age changes add to the underlying genetic neuropathy, so problems with balance and hands may increase with age. NCBI+1

19. Immobilization after fractures or surgery
    Long periods in a cast or bed rest can rapidly weaken already fragile muscles and joints in CMT1D. Again this does not cause the gene change but worsens the clinical picture. NCBI+1

20. Lack of early diagnosis and support
    When CMT1D is not recognised early, people may not receive braces, physiotherapy, or genetic counseling in time. This can allow preventable deformities and injuries to develop, making disability greater even though the underlying gene mutation is the same. ScienceDirect+2Charcot-Marie-Tooth Association+2

Symptoms

1. Gait problems and tripping
   One of the first signs is often a strange way of walking. People may lift their knees very high or slap their feet on the ground because they cannot lift the front of the foot well (“foot drop”). This leads to frequent tripping and falls, especially on uneven ground. Mayo Clinic+1

2. Weakness in feet and ankles
   Muscles that lift and turn the foot become weak. It becomes hard to stand on the heels, run, or climb stairs. The ankles may feel loose or unstable, and sprains are common. Global Genes+1

3. Muscle wasting in lower legs (“inverted champagne bottle” legs)
   Over time, the small muscles of the lower legs shrink. The legs may look thin below the knees, while the thighs look larger. This classic shape is often seen in CMT, including CMT1D. Springer+1

4. Foot deformities (high arches, hammertoes)
   The imbalance between weak and relatively strong muscles pulls the foot into abnormal shapes. High arched feet (pes cavus) and curled toes (hammertoes) are frequent. These deformities can cause pain, calluses, and trouble finding comfortable shoes. Mayo Clinic+1

5. Reduced reflexes
   Reflexes at the ankles and sometimes at the knees often become very weak or disappear. A neurologist can detect this with a reflex hammer. Loss of reflexes is a strong clue that the nerves are not working well. NCBI+1

6. Numbness and reduced feeling in feet and hands
   Sensory nerves are also affected. People may feel tingling, burning, or numbness in the toes and feet. Later, reduced sensation can appear in the fingers. This makes it harder to feel small objects or detect injuries. Mayo Clinic+1

7. Hand weakness and clumsiness
   As the disease progresses, small hand muscles may weaken. Tasks like writing, buttoning clothes, or opening jars become difficult. People may notice they drop things more often. Mayo Clinic+1

8. Poor balance and falls
   Weak muscles, numb feet, and ankle instability combine to disturb balance. Walking in the dark or on soft surfaces can be especially hard. Falls and fear of falling can limit daily activities. nhs.uk+1

9. Neuropathic pain or discomfort
   Some people with CMT1D feel burning, stabbing, or electric-like pains in the feet or legs. Others feel tightness or cramps. Pain level varies widely and is not always related to how weak the muscles look. NCBI+1

10. Muscle cramps and fatigue
    Muscles that are partly weak tire quickly. Cramps, especially at night, are common. People may feel exhausted after walking short distances or after standing for long periods. NCBI+1

11. Scoliosis (curved spine)
    In some patients, long-term muscle imbalance in the back can cause scoliosis. This may lead to back pain, shortness of breath, or cosmetic concerns, especially in teenagers. Global Genes+1

12. Tremor or shaky movements (in some cases)
    Some CMT types can cause tremor in the hands or upper limbs, making fine tasks harder. This has been described in several demyelinating forms and can appear in CMT1D as part of a wider phenotype. Charcot-Marie-Tooth Association+1

13. Vocal cord problems and voice changes (in some CMT1D cases)
    Rarely, EGR2-related neuropathy can affect nerves to the vocal cords, causing hoarseness, weak voice, or breathing difficulty. This is not common but is important to recognise. Global Genes+1

14. Double vision or facial weakness (rare)
    In a few reported patients, cranial nerve involvement has caused double vision (diplopia) or weakness of facial muscles, showing that disease is not limited strictly to limb nerves in some EGR2 mutations. Mattioli 1885+1

15. Emotional and social impact
    Long-term physical disability, visible deformities, and fatigue can affect mood, confidence, and social life. People may feel anxious, sad, or worried about the future or about family members who might also have the gene. Psychological support can be very helpful. NCBI+1

Diagnostic tests

Doctors diagnose CMT1D using a step-by-step process. First they listen to the history and examine the body. Then they perform electrodiagnostic tests to see how fast and how well the nerves work. After that, they use genetic testing to look directly for mutations in CMT genes, including EGR2. Sometimes imaging or biopsy is needed. In most cases, diagnosis can be made without surgery. Massachusetts General Hospital+3NCBI+3Charcot-Marie-Tooth Association+3

Physical examination tests

1. General neurological examination
   The doctor checks muscle strength in the legs and arms, looks for wasting, and tests coordination and tone. Weakness mainly in the feet and lower legs, with milder or later involvement of the hands, suggests a length-dependent neuropathy like CMT1D. NCBI+1

2. Gait and posture assessment
   The doctor watches the way the person walks, turns, and stands. A high-stepping gait, foot drop, or ankle instability give important clues. The doctor may also look for scoliosis, rounded shoulders, or other postural changes caused by long-term muscle imbalance. Mayo Clinic+1

3. Foot and hand inspection
   The feet and hands are examined for deformities such as high arches, hammertoes, claw toes, or thin hand muscles. Skin changes, calluses, and pressure points show how the person walks and bears weight. These visible signs strongly support a diagnosis of CMT. Mayo Clinic+1

4. Sensory testing
   The doctor lightly touches the skin with cotton, pin, tuning fork, and warm or cold objects to check for touch, pain, vibration, and temperature. In CMT1D, sensation usually decreases in a “glove and stocking” pattern, starting in the feet and later the hands. NCBI+1

5. Reflex testing
   Using a reflex hammer, the doctor taps tendons at the ankle and knee. In demyelinating neuropathies like CMT1D, these reflexes are often weak or absent, especially at the ankles. This helps distinguish neuropathy from muscle diseases, where reflexes can be preserved. NCBI+1

Manual and bedside functional tests

6. Manual muscle testing (MRC scale)
   The doctor asks the person to move joints against resistance (for example, lifting the foot up while the doctor pushes down) and grades strength on a standard scale. Patterned weakness of ankle dorsiflexion and toe extension, with less weakness in the hips, fits with CMT1D. NCBI+1

7. Heel, toe, and tandem walking tests
   The person is asked to walk on heels, on toes, and in a straight line placing one foot directly in front of the other (tandem gait). Difficulty with heel walking points to weakness of muscles that lift the foot, common in CMT. Balance problems during tandem walking show sensory and motor involvement. nhs.uk+1

8. Romberg test (balance test)
   The person stands with feet together and eyes open, then closes the eyes. If they sway or fall more with eyes closed, this suggests impaired sensation from the feet (proprioception) together with weakness, which fits with peripheral neuropathy such as CMT1D. NCBI+1

9. Timed walking tests (for example 10-meter walk)
   Simple timed tests, such as how long it takes to walk 10 meters, help measure walking speed and function. Repeating the test over time allows doctors to see how quickly the disease is progressing and whether therapies such as physiotherapy are helping. NCBI+1

10. Functional hand tests
    Tasks such as buttoning a shirt, picking up coins, or writing are observed. Slowness, clumsiness, or obvious weakness in finger movements can show how far the neuropathy has spread to the hands and how it affects daily life. Mayo Clinic+1

Laboratory and pathological tests

11. Routine blood tests to rule out other causes
    Blood tests for blood sugar, vitamin B12, thyroid function, and other markers help make sure symptoms are not mainly due to another treatable cause of neuropathy, such as diabetes or vitamin deficiency. In pure CMT1D, these tests are usually normal. ARUP Consult+1

12. CMT gene panel testing (including EGR2)
    A blood or saliva sample is sent to a genetic lab for a “CMT gene panel”. This test looks at many genes known to cause CMT, including EGR2. When a harmful EGR2 mutation is found together with demyelinating nerve conduction, the diagnosis of CMT1D is confirmed. Charcot-Marie-Tooth Association+2Mayo Clinic+2

13. Targeted EGR2 gene sequencing
    If a specific EGR2 mutation is already known in the family, a simpler, targeted test can be done to see whether another family member has the same change. This is useful for family planning and for identifying people who might benefit from early monitoring and support. NCBI+2American Academy of Neurology+2

14. Nerve biopsy (now rarely needed)
    In the past, doctors often took small pieces of a nerve (usually from the lower leg) to study under a microscope. In demyelinating CMT like CMT1D, this showed thin myelin and onion-bulb formations. Today, because genetic and nerve conduction tests are so good, nerve biopsy is used only in difficult or unclear cases. Wikipedia+2Neurology Asia+2

Electrodiagnostic tests

15. Motor nerve conduction studies (NCS)
    Small electric shocks are given to nerves in the arms and legs, and the response in the muscles is measured. In CMT1D, conduction velocity is greatly reduced (very slow signals), which is typical of demyelinating neuropathy. This helps distinguish CMT1 from axonal CMT2. MalaCards+2Mayo Clinic+2

16. Sensory nerve conduction studies
    Similar tests measure responses in purely sensory nerves. Reduced or absent sensory responses, with very slow conduction, confirm that both motor and sensory fibers are involved and support the diagnosis of hereditary motor and sensory neuropathy (HMSN) type 1D. NCBI+1

17. Electromyography (EMG)
    A fine needle electrode is inserted into muscles to record their electrical activity. EMG in CMT1D often shows signs of chronic denervation and reinnervation, matching the slow, long-term neuropathy. EMG also helps exclude primary muscle diseases. Mayo Clinic+1

Imaging tests

18. Spinal X-rays for scoliosis
    If the doctor suspects scoliosis, simple X-rays of the spine show the degree and shape of the curve. This is important for planning physiotherapy, bracing, or, in some cases, surgery to prevent breathing problems or back pain. Global Genes+1

19. Foot and ankle X-rays
    X-rays of the feet and ankles show bone alignment, joint damage, and the exact shape of deformities such as pes cavus and hammertoes. These images help orthopedic surgeons and podiatrists design braces, custom shoes, or corrective surgeries if needed. Mayo Clinic+1

20. MRI or ultrasound of peripheral nerves (in selected cases)
    In some centres, imaging such as MRI neurography or high-resolution ultrasound is used to look at the structure of peripheral nerves. In demyelinating neuropathies, nerves may appear thickened. This is not always required for routine diagnosis but can be helpful in complex or research situations. NCBI+1

Non-Pharmacological Treatments (therapies and other measures)

Important note: Not every person with CMT1D needs every therapy below. The neurologist and rehab team choose the best mix for each patient.

1. Individual physiotherapy (PT) program
   A personal PT plan uses simple, repeated movements to keep muscles working as well as possible. The therapist chooses safe exercises based on strength, balance, and fatigue levels. The purpose is to slow muscle wasting and keep joints flexible. The main mechanism is “use it or lose it”: regular, gentle loading helps nerves and muscles stay active and delays contractures. ResearchGate+2Mayo Clinic+2

2. Stretching to prevent contractures
   Short, tight muscles around the ankle, knee, and fingers are common in CMT1D. Daily slow stretches, held for 20–30 seconds, can reduce stiffness and prevent permanent bending of joints. The purpose is to keep the full range of motion. Stretching acts by gently lengthening muscle and tendon fibers and reducing abnormal muscle tone. ResearchGate+2Ciència i Salut+2

3. Strengthening exercises
   Low-resistance strengthening (for example, light bands or water exercises) can help preserve remaining muscle power. The purpose is not to “build big muscles” but to keep them working against gravity. The mechanism is mild muscle overload that stimulates nerve-muscle units without causing over-fatigue or damage. ResearchGate+2PMC+2

4. Balance and gait training
   Weak muscles and poor feeling in the feet cause unsteady walking. Balance training includes standing on different surfaces, stepping exercises, and practicing safe turns. The purpose is to reduce falls and improve confidence. The mechanism is brain “re-training” using repeated practice and visual cues to compensate for damaged sensory nerves. ResearchGate+2ScienceDirect+2

5. Aerobic / endurance exercise
   Gentle activities such as cycling, swimming, or walking in water can improve heart and lung fitness without overloading weak muscles. The purpose is to reduce fatigue, keep weight healthy, and improve mood. The mechanism includes better blood flow to nerves, improved mitochondrial function, and reduced inflammation. ResearchGate+2ScienceDirect+2

6. Occupational therapy (OT) for hand function
   OT teaches easier ways to do daily tasks like buttoning, writing, or cooking, and may provide adaptive tools (large-grip pens, button hooks, modified cutlery). The purpose is to protect independence. The mechanism is activity adaptation: changing the tool or the method so weak hands can still do complex tasks without pain. ResearchGate+1

7. Ankle-foot orthoses (AFOs)
   AFOs are stiff or semi-flexible braces that hold the ankle at a right angle. They prevent “foot drop,” stabilize the ankle, and help lift the toes during walking. The purpose is safer, more efficient gait and fewer falls. The mechanism is simple mechanical support that replaces lost muscle power. ScienceDirect+2WonderFlora & CMT Alapítvány+2

8. Custom footwear and insoles
   People with CMT often have very high arches or hammertoes. Custom shoes, molded insoles, and soft linings protect pressure points, reduce pain, and prevent ulcers. The mechanism is better pressure distribution and improved foot alignment during stance and push-off. ResearchGate+2WonderFlora & CMT Alapítvány+2

9. Hand and wrist splints
   Splints or braces can support weak wrists or fingers to improve grip and alignment and to prevent deformities. The purpose is to stabilize joints for tasks like typing or holding objects. The mechanism is external support that reduces strain on weak muscles and tendons. ResearchGate+1

10. Walking aids (cane, crutches, walker)
    Some people need extra support to walk safely. A cane held in the stronger hand, elbow crutches, or a wheeled walker can reduce falls and fear of falling. The mechanism is widening the base of support and giving the brain extra sensory feedback through the hands. ResearchGate+1

11. Respiratory and speech therapy (if needed)
    A few people with CMT1D have breathing muscle weakness or vocal cord problems. Breathing exercises, cough training, and non-invasive ventilation support can protect lung function. Speech therapy helps with voice strength and speech clarity. The mechanism is targeted training of the respiratory and laryngeal muscles. Genetic & Rare Diseases Center+2Mayo Clinic+2

12. Cognitive-behavioral therapy (CBT) for chronic pain
    Chronic neuropathic pain often continues even when nerves cannot be “fixed.” CBT teaches coping skills, pacing, and relaxation. The purpose is to reduce suffering, even if pain level is not zero. The mechanism is changing thought patterns and behaviors that increase pain perception and focusing attention on helpful activities. PMC+2ScienceDirect+2

13. Fatigue management and energy conservation
    Therapists teach “work-rest” cycles, planning tasks, and using wheelchairs or scooters for long distances. The goal is to save energy for the most important activities. The mechanism is reducing overuse of weak muscles and preventing “boom-and-bust” cycles of activity and exhaustion. ResearchGate+1

14. Home safety modifications
    Simple changes such as removing loose rugs, adding grab bars, using night lights, and installing handrails on both sides of stairs can prevent serious injuries. The mechanism is environmental control: lowering fall risk that comes from poor balance and numb feet. ScienceDirect+1

15. Vocational and school adaptations
    Young people with CMT1D may need extra time for writing, computer access, or ergonomic changes at work. Vocational rehab services look at job tasks and suggest reasonable adjustments. The mechanism is matching physical ability with job demands so that work is safe and sustainable. ResearchGate+1

16. Genetic counseling
    Because CMT1D is genetic, families often want to understand inheritance, testing options, and pregnancy choices. Genetic counselors explain risks in simple language and help with emotional decisions. The mechanism is informed decision-making and early diagnosis in other family members if they wish. Genetic & Rare Diseases Center+2Mayo Clinic+2

17. Psychological support and peer groups
    Living with a slowly progressive disease can cause anxiety, low mood, and social isolation. Support groups and counseling help people share fears, learn coping strategies, and feel less alone. The mechanism is emotional support and normalization of feelings. ResearchGate+1

18. Foot and skin care education
    Weakness and numbness increase the risk of unnoticed wounds. Education includes daily foot checks, nail care, proper socks, and early reporting of blisters or ulcers. The mechanism is early detection and prevention of infections and deformities. ResearchGate+1

19. Sleep hygiene and management of sleep problems
    Pain, cramps, or breathing issues can disturb sleep. Good sleep habits (fixed bedtime, avoiding screens late at night) and treatment of sleep apnea if present help daytime energy. The mechanism is better restorative sleep which improves pain tolerance and mood. PMC+1

20. Healthy weight and lifestyle coaching
    Extra body weight puts more stress on weak feet and ankles. A balanced diet, gentle activity, and avoiding smoking help keep nerves and blood vessels healthier. The mechanism is lowering mechanical load and improving overall metabolic health, which supports nerve function. ScienceDirect+2PMC+2

---

Drug Treatments

Key safety point:
No medicine is currently approved specifically for Charcot-Marie-Tooth disease. All drugs below target symptoms such as neuropathic pain, cramps, mood problems or sleep. Doses and choices must be decided by a doctor; never start, stop, or change any drug on your own. NMD Journal+2PMC+2

Where possible, typical adult doses come from FDA labels or major guidelines; exact dose and schedule differ by age, kidney function, liver function, and other medicines.

1. Gabapentin
   Gabapentin is an anti-seizure medicine widely used for nerve pain. FDA labels show it is approved for post-herpetic neuralgia and seizures, usually started around 300 mg/day in adults and slowly increased, often up to 1800–3600 mg/day in divided doses. PMC+3FDA Access Data+3FDA Access Data+3
   Purpose: reduce burning, shooting, or tingling pain.
   Mechanism: it binds to calcium channels in nerve cells and reduces abnormal pain messaging. Common side effects include sleepiness, dizziness, and swelling in the legs.

2. Pregabalin
   Pregabalin (Lyrica) is FDA-approved for neuropathic pain from diabetes, spinal cord injury, and post-herpetic neuralgia, with common starting doses of 75 mg twice daily in adults and maximum doses up to 600 mg/day. Wikipedia+3FDA Access Data+3FDA Access Data+3
   Purpose: control moderate to severe nerve pain and improve sleep.
   Mechanism: similar to gabapentin, it reduces abnormal electrical signaling in pain pathways. Side effects include dizziness, weight gain, blurred vision, and sometimes swelling or mood changes.

3. Duloxetine
   Duloxetine (Cymbalta, Drizalma Sprinkle) is an SNRI antidepressant approved for diabetic nerve pain, fibromyalgia, and depression, often used at 30–60 mg/day and up to 120 mg/day in adults. Northern Lincolnshire APC+3FDA Access Data+3FDA Access Data+3
   Purpose: treat neuropathic pain, low mood, and anxiety at the same time.
   Mechanism: increases serotonin and norepinephrine in the brain and spinal cord, improving the way pain signals are processed. Side effects include nausea, dry mouth, sweating, and increased blood pressure.

4. Amitriptyline (low dose)
   Amitriptyline is an older tricyclic antidepressant widely recommended as first or second-line treatment for neuropathic pain, often used at low bedtime doses such as 10–25 mg and slowly increased if tolerated. Wikipedia+3Northern Lincolnshire APC+3Derbyshire Medicines Management+3
   Purpose: help pain and improve sleep.
   Mechanism: blocks reuptake of serotonin and norepinephrine and also calms overactive pain pathways. Side effects include dry mouth, constipation, weight gain, and drowsiness; it must be used with care in heart disease.

5. Nortriptyline
   Nortriptyline is similar to amitriptyline but often better tolerated. It is used off-label for nerve pain at low bedtime doses, titrated slowly. PMC+1
   Purpose: alternative when amitriptyline is too sedating.
   Mechanism: similar SNRI-type effect with fewer anticholinergic side effects. Possible side effects include dry mouth, blurred vision, constipation, and heart rhythm changes.

6. Venlafaxine (extended release)
   Venlafaxine is an SNRI antidepressant used off-label for neuropathic pain. Guidelines mention it as another option when first-line agents fail. PMC+2وزارة الصحة السعودية+2
   Purpose: treat pain plus depression/anxiety.
   Mechanism: increases serotonin and norepinephrine in pain-modulating pathways. Side effects include nausea, sweating, raised blood pressure, and insomnia.

7. Topical lidocaine 5% patch
   Lidocaine patches are FDA-approved for post-herpetic neuralgia and are sometimes used for localized neuropathic pain in the feet. PMC+2وزارة الصحة السعودية+2
   Purpose: numb a small painful area (for example, on the top of the foot).
   Mechanism: blocks sodium channels in superficial nerves so they cannot send pain signals. Side effects are usually mild, such as local redness.

8. High-concentration capsaicin patch (8%)
   Capsaicin 8% patch is approved for certain peripheral neuropathic pains and applied under medical supervision. ScienceDirect+1
   Purpose: reduce severe localized burning pain.
   Mechanism: overstimulates and then “switches off” pain fibers that express TRPV1 channels. It can cause strong burning for a short time after application; therefore, it is applied in clinic with protective measures.

9. NSAIDs (such as ibuprofen or naproxen)
   Non-steroidal anti-inflammatory drugs help mechanical and joint pain due to deformities or overuse, but they weakly affect pure neuropathic pain. PMC+1
   Purpose: treat muscle, tendon, and joint pain from abnormal gait.
   Mechanism: block COX enzymes to reduce prostaglandins and inflammation. Side effects include stomach irritation, kidney strain, and increased bleeding risk, especially at higher doses or long term.

10. Acetaminophen (paracetamol)
    Acetaminophen is often used as a simple pain reliever for mild musculoskeletal discomfort. It does not treat nerve pain directly but can be part of combination therapy. PMC+1
    Mechanism: acts in the central nervous system to reduce pain perception. High doses can harm the liver, so total daily dose must stay within safe limits set by regulatory agencies.

11. Tramadol (short-term use)
    Tramadol is an opioid-like painkiller sometimes used for short periods of severe neuropathic pain when first-line drugs are not enough. Guidelines warn against long-term use and dependence. Dove Medical Press+3Derbyshire Medicines Management+3ScienceDirect+3
    Mechanism: weak opioid agonist plus serotonin and norepinephrine reuptake inhibition. Side effects include nausea, constipation, dizziness, and risk of dependence and serotonin syndrome with other serotonergic drugs.

12. Carbamazepine / oxcarbazepine
    These anti-seizure drugs are classic treatments for trigeminal neuralgia and sometimes used for other nerve pains. PainData+1
    Mechanism: block sodium channels and stabilize overactive neurons. Side effects include dizziness, low sodium, rash, and blood count changes. They must be monitored by a doctor.

13. Baclofen
    Baclofen is a muscle relaxant that targets spasticity. In CMT1D, it can be used if there is increased muscle tone or painful spasms. PMC+1
    Mechanism: acts on GABA-B receptors in the spinal cord to reduce reflex muscle contractions. Side effects include drowsiness and weakness, so doses must be increased slowly.

14. Tizanidine
    Tizanidine is another muscle relaxant used for spasticity and cramps. PMC+1
    Mechanism: alpha-2 adrenergic agonist that reduces excitatory signals to motor neurons. Side effects include low blood pressure, sleepiness, and dry mouth. Liver function should be monitored.

15. Botulinum toxin A (local injections)
    Botulinum toxin A is injected into overactive muscles to reduce spasms, abnormal postures, or pain in focal areas. In CMT, it might be used in selected cases with severe deformities or cramps. ScienceDirect+1
    Mechanism: blocks acetylcholine release at the neuromuscular junction, relaxing the target muscle for several months. Side effects are usually local, like temporary weakness.

16. Selective serotonin reuptake inhibitors (SSRIs, e.g., sertraline)
    SSRIs do not directly treat neuropathic pain, but many people with CMT1D have depression or anxiety associated with chronic disability. PMC+1
    Mechanism: increase serotonin levels in the brain, improving mood and coping. They can indirectly help pain by improving sleep and emotional resilience.

17. Melatonin (as a medicine)
    In some countries, melatonin is used as a drug for sleep problems. Sleep disruption worsens pain and fatigue. PMC+1
    Mechanism: supports natural sleep-wake cycles. Side effects are usually mild, such as morning sleepiness or vivid dreams.

18. Topical diclofenac gel
    For localized joint or tendon pain (for example, around the ankle), topical diclofenac gel can be useful, with lower systemic exposure than oral NSAIDs. PMC+1
    Mechanism: local anti-inflammatory action through COX inhibition in tissues under the skin.

19. Magnesium (as a prescribed supplement for cramps)
    In some cases, doctors prescribe magnesium for muscle cramps, especially if blood magnesium is low. PMC+1
    Mechanism: supports normal muscle and nerve function and may reduce excitability of muscle cells. Too much can cause diarrhea and, in kidney disease, serious toxicity.

20. Combination therapy (for example, gabapentin + amitriptyline or pregabalin + duloxetine)
    Guidelines support combining drugs from different classes when single-drug therapy is not enough, but this must be done carefully by specialists. وزارة الصحة السعودية+3PMC+3Dove Medical Press+3
    Mechanism: attacks pain through several pathways at lower doses of each drug, which may give good relief with fewer side effects.

---

Dietary Molecular Supplements

Important: Evidence for supplements in CMT1D is limited. Most data come from general nerve health or other neuropathies. Always discuss supplements with a doctor, especially if you take other medicines.

1. Vitamin B12 (methylcobalamin)
   Vitamin B12 is essential for myelin and nerve repair. Low B12 can worsen neuropathy. Supplementation, often 500–1000 mcg/day orally in deficiency, can correct low levels and support normal nerve function. Mechanism: co-factor in myelin synthesis and DNA repair; helps reduce homocysteine, which can damage vessels and nerves. Wikipedia+1

2. B-complex (B1, B6, B12)
   Balanced B-complex supplements provide several B vitamins that work together in energy production and nerve health. Excess vitamin B6, however, can itself cause neuropathy, so doses should stay in safe ranges. Mechanism: supports energy metabolism in neurons and myelin maintenance. Wikipedia+1

3. Alpha-lipoic acid
   Alpha-lipoic acid is an antioxidant used in some countries for diabetic neuropathy. Typical studied doses are 600 mg/day. It may reduce oxidative stress and improve microcirculation around nerves. Mechanism: scavenges free radicals, regenerates other antioxidants, and may improve nerve blood flow. PMC+1

4. Coenzyme Q10 (CoQ10)
   CoQ10 helps mitochondria make energy. In neuropathy, mitochondrial stress may worsen nerve damage. Doses in studies often range from 100–300 mg/day. Mechanism: improves electron transport chain function and reduces oxidative damage. Evidence in CMT is limited but biologically plausible. Wikipedia+1

5. Omega-3 fatty acids (EPA/DHA)
   Fish-oil-derived omega-3s at doses of around 1–3 g/day are used for heart health and have anti-inflammatory effects. Mechanism: incorporate into cell membranes, reduce pro-inflammatory eicosanoids, and may support nerve regeneration after injury. Wikipedia+1

6. Vitamin D
   Vitamin D deficiency is common and may be linked with muscle weakness and immune problems. Replacement doses depend on blood levels, often 800–2000 IU/day or tailored by a doctor. Mechanism: modulates immune function, supports muscle strength, and may protect neurons through calcium regulation. Wikipedia+1

7. Magnesium (dietary form)
   Dietary magnesium (through food or low-dose supplements) supports normal muscle and nerve activity. It may help cramps, especially when blood levels are low. Mechanism: stabilizes nerve membranes and acts as a natural calcium blocker at NMDA receptors, reducing excitability. Wikipedia+1

8. L-carnitine / acetyl-L-carnitine
   L-carnitine helps transport fatty acids into mitochondria. Some small studies in neuropathy suggest possible symptom relief. Mechanism: supports mitochondrial energy production and may promote nerve fiber regeneration. Dose varies, often 1–3 g/day in studies, but must be supervised. Wikipedia+1

9. Curcumin (turmeric extract)
   Curcumin has anti-inflammatory and antioxidant properties. It may reduce inflammatory pain and oxidative damage to nerves. Mechanism: downregulates NF-κB and pro-inflammatory cytokines, and acts as a free radical scavenger. Bioavailability is higher in special formulations combined with piperine or lipids. Wikipedia+1

10. Resveratrol
    Resveratrol is a plant polyphenol found in grapes and berries. Animal studies suggest it may protect nerves by activating antioxidant pathways and improving mitochondrial function. Mechanism: activates SIRT1 and related pathways, reducing oxidative stress and inflammation. Human evidence in CMT is very limited, so it should be considered experimental. Wikipedia+1

---

Regenerative / Stem-Cell / Immuno-Modulating Therapies

For CMT1D, these approaches are research only. None are standard care or approved specifically for this disease.

1. NT-3 gene therapy (AAV1.NT-3)
   Gene therapy delivering neurotrophin-3 (NT-3) via AAV vectors has shown improved nerve conduction and muscle function in mouse models and an early human trial for CMT1A. LinkedIn+4PMC+4ResearchGate+4
   Mechanism: NT-3 supports myelinating Schwann cells and axonal growth. Doses and schedules are defined only inside clinical trials; outside trials this therapy is not available.

2. Plasmid HGF gene therapy (Engensis/VM202)
   Engensis is a non-viral plasmid DNA therapy expressing hepatocyte growth factor (HGF). It has an FDA regenerative medicine designation and is being studied in several neuropathies, including Charcot-Marie-Tooth disease. Wikipedia+1
   Mechanism: promotes nerve regeneration and new blood vessel growth. Dosing is strictly controlled in research protocols.

3. Mesenchymal stem cell (MSC) therapy for peripheral neuropathy
   MSCs from bone marrow or umbilical cord are being tested for diabetic neuropathy and peripheral nerve injuries. Animal and early human studies show improved nerve conduction and reduced pain, but not yet specific for CMT1D. Lippincott Journals+4PMC+4Frontiers+4
   Mechanism: MSCs release growth factors and anti-inflammatory molecules that support nerve repair. Therapy is experimental, with dosing and routes decided only in trials.

4. Muse cells and other advanced cell therapies
   Multilineage-differentiating stress-enduring (Muse) cells have reduced neuropathic pain and neuro-inflammation in mouse models. arXiv+1
   Mechanism: immunomodulation and secretion of anti-inflammatory cytokines such as TGF-β and IL-10, improving nerve environment. This is still at pre-clinical or very early clinical stages.

5. Acellular nerve allografts and nerve scaffolds
   Acellular nerve allografts (such as Avance) are FDA-approved for repairing nerve gaps after injury. Wikipedia+1
   Mechanism: provide a scaffold that guides regrowth of nerve fibers. In CMT, they may be used only in special surgical situations, not as a general disease therapy.

6. Antisense and gene-editing approaches
   Antisense oligonucleotides (ASOs) and other genetic tools are being studied for many inherited nerve diseases. For CMT, gene-based therapies targeting myelin genes and other pathways are in pre-clinical or early clinical development. NMD Journal+2Wikipedia+2
   Mechanism: silence or correct harmful genes or change RNA splicing. At present, these treatments are not available for routine use in CMT1D, and no safe standard dose exists.

---

Surgeries (procedures and why they are done)

Surgery in CMT1D mainly targets foot and ankle deformities and, sometimes, spinal deformity or nerve entrapment. It should be planned by surgeons experienced in CMT. WonderFlora & CMT Alapítvány+2Ciència i Salut+2

1. Soft-tissue releases (tendon lengthening, plantar fascia release)
   These operations lengthen tight tendons and soft tissues around the ankle or under the foot to reduce fixed equinus (toe-walking) and high arches. Purpose: improve foot position, allow flat standing, and make bracing easier. Mechanism: surgically relaxes tight structures that resist normal alignment.

2. Tendon transfers
   Tendon transfers move a working muscle tendon (for example, tibialis posterior) to replace a weak muscle (such as the muscles that lift the foot). Purpose: restore active dorsiflexion and reduce foot drop, making walking safer. Mechanism: rerouting muscle power to a new position so that muscle pull corrects deformity instead of worsening it.

3. Osteotomies (bone cuts) of the foot
   In severe pes cavus (very high arch), surgeons cut and realign foot bones to create a more balanced structure. Purpose: distribute pressure more evenly and prevent recurrent ulcers and pain. Mechanism: changes bone angles so that tendons and ligaments work in a more neutral position.

4. Arthrodesis (joint fusion)
   In advanced, rigid deformities with arthritis, fusing joints (for example, triple arthrodesis of the hindfoot) may be needed. Purpose: create a stable, plantigrade (flat) foot even if flexibility is lost. Mechanism: permanently joins bones, removing painful abnormal motion but also reducing joint movement.

5. Spinal surgery (for scoliosis) or nerve decompression
   If scoliosis becomes severe and affects breathing or causes pain, spinal fusion may be required. In selected cases, decompression of compressed nerves (like carpal tunnel) can relieve extra nerve pressure. Purpose: protect lung function, relieve pain, and prevent progression of deformity. Mechanism: mechanical stabilization or decompression of bone and soft tissue around nerves or spine.

---

Preventions

CMT1D itself cannot usually be prevented because it is genetic. However, many complications can be reduced or delayed:

1. Early diagnosis and regular follow-up – allows early PT, orthotics, and surgery planning before severe deformities form. ResearchGate+2Ciència i Salut+2

2. Daily stretching and wearing orthoses as prescribed – prevents fixed contractures and permanent joint deformities. ResearchGate+1

3. Foot care and protective footwear – prevents ulcers, infections, and fractures from unnoticed injuries. WonderFlora & CMT Alapítvány+1

4. Fall-prevention strategies – using aids when needed, keeping floors clear, installing grab bars to prevent dangerous falls and head injuries. ScienceDirect+1

5. Healthy weight control – avoids extra stress on weak ankles and feet and reduces surgical risks. PMC+1

6. Vaccinations and infection prevention – routine vaccines (like flu and pneumonia) help avoid infections that could worsen weakness or cause hospital stays. Wikipedia+1

7. Avoiding nerve-toxic drugs (for example, some chemotherapy agents) when possible – doctors try to choose treatments with lower neuropathy risk if you already have CMT. Wikipedia+1

8. Smoking avoidance and good vascular health – smoking and uncontrolled diabetes can worsen nerve damage; avoiding them protects remaining nerve function. Wikipedia+1

9. Genetic counseling before pregnancy – helps families understand inheritance and options like prenatal or pre-implantation testing if they wish. Genetic & Rare Diseases Center+1

10. Early treatment of mood and sleep problems – preventing long-term depression, anxiety, and chronic insomnia helps people stay active and engaged in therapy. PMC+1

---

When to See a Doctor

You should see a doctor (preferably a neurologist with experience in neuromuscular diseases) if you notice:

• new or worsening weakness in feet, legs, or hands

• increasing difficulty walking, frequent falls, or sudden change in gait

• new or severe burning, shooting, or electric-like pain in the limbs

• swallowing problems, breathlessness at rest or at night, or morning headaches (possible breathing issues)

• rapid change in spine curve or new back pain

• foot wounds, color changes, or swelling that do not heal

Regular follow-up visits are important even if you feel stable, because doctors can adjust braces, therapies, and pain treatment over time and watch for treatable complications. ResearchGate+2Ciència i Salut+2

---

What to Eat and What to Avoid

1. Eat a balanced, whole-food diet – plenty of vegetables, fruits, whole grains, lean protein, and healthy fats supports overall nerve and muscle health. Wikipedia+1

2. Include omega-3-rich foods – such as fatty fish (if allowed), flax, and walnuts, which may help reduce inflammation. Wikipedia+1

3. Ensure enough B-vitamins and vitamin D – through diet and, if needed, doctor-guided supplements, to support myelin and muscle function. Wikipedia+1

4. Choose complex carbohydrates – like brown rice, oats, and beans to give steady energy and avoid large sugar spikes that may harm nerves in the long term. Wikipedia

5. Stay well-hydrated – water helps muscles and joints work smoothly and can reduce cramps in some people. Wikipedia+1

6. Limit ultra-processed foods and excess sugar – these can worsen weight gain and inflammation, which increase mechanical stress on weak feet and ankles. Wikipedia+1

7. Avoid excessive alcohol – alcohol directly damages peripheral nerves and can worsen neuropathy from any cause. Wikipedia

8. Avoid extreme crash diets – rapid weight loss and nutrient deficiency can weaken muscles further and slow recovery after surgery. Wikipedia+1

9. Limit high-salt, high-fat fast foods – to protect heart and blood vessels and reduce edema that can worsen pain and swelling in the legs. Wikipedia

10. Discuss any “nerve health” supplements with your doctor – some herbal products can interact with pain medicines or blood thinners; professional guidance keeps things safe. Wikipedia+1

---

Frequently Asked Questions

1. Is Charcot-Marie-Tooth disease type 1D curable?
No. At this time, CMT1D has no cure and no approved disease-modifying drug. Treatment focuses on symptoms and function, while research explores gene and regenerative therapies. NMD Journal+2ResearchGate+2

2. Will everyone with CMT1D end up in a wheelchair?
Not always. The severity and speed of progression vary. Many people walk independently for decades with good physiotherapy, braces, and timely surgery. Some may eventually need a wheelchair for long distances. Genetic & Rare Diseases Center+2Mayo Clinic+2

3. Are non-drug treatments really as important as medicines?
Yes. Guidelines stress that physiotherapy, orthotics, and surgery are central in CMT care, while drugs mainly treat pain and associated problems. Non-pharmacological care can strongly affect long-term mobility and quality of life. ResearchGate+2Ciència i Salut+2

4. Can exercise make CMT1D worse?
Gentle, well-planned exercise usually helps rather than harms. Over-strenuous activity that causes strong pain or long-lasting fatigue may be harmful. Working with a physiotherapist familiar with neuromuscular disease is safest. ResearchGate+2PMC+2

5. Why are gabapentin and pregabalin used if they are not tested specifically in CMT?
These medicines are approved and well-studied for other neuropathic pains, and guidelines recommend them as first-line agents for chronic nerve pain in general. Doctors use them “off-label” in CMT-related pain when benefits outweigh risks. Wikipedia+4PMC+4Northern Lincolnshire APC+4

6. Do pain medicines slow the disease itself?
No. Pain medicines improve comfort and sleep but do not change the underlying gene mutation or nerve damage. They are supportive, not curative. NMD Journal+1

7. Are stem cell treatments in private clinics safe for CMT?
Many commercial “stem cell” offers are unproven and may be unsafe or very expensive. Real stem-cell and gene therapies for neuropathy are still in controlled clinical trials. Always check whether a treatment is part of a registered trial and approved by health authorities. NMD Journal+4PMC+4MDPI+4

8. Can diet alone cure CMT1D?
No diet can fix the EGR2 gene mutation. However, healthy eating supports muscle strength, weight control, and overall health, which indirectly helps you cope better with the disease. Genetic & Rare Diseases Center+2Wikipedia+2

9. Is pregnancy dangerous if I have CMT1D?
Many people with CMT have healthy pregnancies. However, symptoms such as weakness or balance problems may temporarily worsen, and genetic transmission risk needs to be discussed. Pre-pregnancy counseling with neurology and genetics teams is recommended. Genetic & Rare Diseases Center+2Global Genes+2

10. Will my children definitely have CMT1D?
CMT1D is usually autosomal dominant, so each child has a 50% chance of inheriting the mutation if one parent is affected, but this must be confirmed by genetic testing. Some families show variable severity, even within siblings. Genetic & Rare Diseases Center+2Global Genes+2

11. Is surgery a last resort?
Surgery is not automatically “last resort”; it is used when deformities become fixed or braces no longer work. Expert consensus recommends carefully timed surgery to balance function and recovery. WonderFlora & CMT Alapítvány+2Ciència i Salut+2

12. Are clinical trials available for CMT?
Yes, there are ongoing trials in CMT (for example, NT-3 gene therapy and gene-based treatments in related forms). Availability depends on your location, age, and genetic type. Clinical trial registries and CMT foundations list current studies. NMD Journal+3PMC+3ResearchGate+3

13. Do braces make muscles weaker?
Properly prescribed AFOs usually do not make muscles weaker. They stabilize the ankle and allow safer walking, which can support more activity and better fitness. Stretching and exercises should continue alongside brace use. ResearchGate+2WonderFlora & CMT Alapítvány+2

14. Can children with CMT1D play sports?
Many can take part in low-impact sports (swimming, cycling, walking, some adapted games) with supervision and the right footwear or braces. High-impact contact sports may be risky. The care team can help choose safe activities. ResearchGate+2PMC+2

15. What is the most important single thing I can do?
The most powerful steps are: stay engaged with your care team, keep moving with safe exercise and physiotherapy, use orthoses or aids when advised, look after your feet, and seek emotional support. Together, these can strongly improve quality of life, even if the genetic cause cannot yet be fixed. PMC+3ResearchGate+3Ciència i Salut+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 25, 2025.